Get the Stockscreener App
10.49
0.38%
-0.04
After Hours:
10.30
-0.19
-1.81%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $10.49, with a volume of 9.99M.
It is down -0.38% in the last 24 hours and up +2.94% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$10.53
Open:
$10.44
24h Volume:
9.99M
Relative Volume:
1.07
Market Cap:
$12.23B
Revenue:
$14.33B
Net Income/Loss:
$-3.79B
P/E Ratio:
-3.3091
EPS:
-3.17
Net Cash Flow:
$1.84B
1W Performance:
+1.94%
1M Performance:
+2.94%
6M Performance:
+21.27%
1Y Performance:
-8.38%
1-Day Range:
$10.36
$10.61
1-Week Range:
$10.22
$10.61
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.49 | 12.16B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Jun-06-25 | Initiated | Goldman | Neutral |
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
Viatris (VTRS) Q3 Earnings Report Preview: What To Look For - TradingView
Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections - Eyes On Eyecare
Policy Engagement to Break Down Barriers to Access and Build Resilient Health Systems at Viatris - ACCESS Newswire
Viatris Inc. Declares Quarterly Dividend, Payable on December 15, 2025 - MarketScreener
Viatris declares quarterly dividend of $0.12 per share - Investing.com
Viatris Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Can Viatris Inc. (VIA) stock surprise markets with earningsTrade Ideas & AI Driven Stock Reports - newser.com
Is it time to cut losses on Viatris Inc.Trade Signal Summary & Low Risk Entry Point Guides - newser.com
Viatris Announces Quarterly Dividend - Yahoo Finance
What’s the recovery path for long term holders of Viatris Inc.July 2025 Final Week & Pattern Based Trade Signal System - newser.com
Is now a turning point for Viatris Inc.July 2025 Retail & Free AI Powered Buy and Sell Recommendations - newser.com
What does recent volatility data suggest for Viatris Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com
Is Viatris Inc. (VIA) stock overpriced at current multiples2025 Price Momentum & Smart Money Movement Tracker - newser.com
Is Viatris Inc. stock recession proofTrade Exit Report & Safe Capital Growth Tips - newser.com
Viatris Inc. stock outlook for YEAR2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Will Viatris Inc. stock recover faster than peersAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Will Viatris Inc. stock return to pre crisis levelsMarket Performance Recap & Consistent Profit Alerts - newser.com
Viatris to Report Q3 Earnings: Is a Beat in the Cards for the Stock? - Zacks Investment Research
Will Viatris Inc. stock benefit from upcoming earnings reportsJuly 2025 Action & Weekly High Potential Alerts - newser.com
Why Viatris Inc. stock could be next big winner2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
3 Stocks Under $50 We’re Skeptical Of - The Globe and Mail
Should you wait for a breakout in Viatris Inc.Trade Volume Report & High Return Stock Watch Alerts - newser.com
What is the fair value estimate for Viatris Inc. (VIA) stock in 20252025 Top Gainers & Daily Price Action Insights - newser.com
Can volume confirm reversal in Viatris Inc.July 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Will Viatris Inc. stock go up soonPortfolio Risk Report & Safe Swing Trade Setup Alerts - newser.com
Will Viatris Inc. stock reach Wall Street targetsTrade Exit Summary & Community Consensus Trade Signals - newser.com
Viatris marked 25 years of advancing cardiovascular health in Vietnam - VnExpress International
Is Viatris Inc. stock a good choice for value investorsPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy? - sharewise.com
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):